Which statement best describes a key advantage of PCR/ESI-TOF in pathogen identification?

Which statement best describes a key advantage of PCR/ESI-TOF in pathogen identification?

• A. Requires the patient sample to be cultured and then analysis can be performed.
• B. Can be used directly from patient specimens.
• C. Uses the protein "finger print" to identify the pathogen.
• D. Requires extensive sample processing.

Answer: (B)

Direct analysis from patient specimens is the main advantage. PCR amplifies small amounts of pathogen DNA in a sample, increasing sensitivity so low-level or hard-to-culture infections can be detected. Pairing that with ESI-TOF mass spectrometry reads the masses of the amplified products, giving a unique signature that matches known pathogens. This lets you identify the organism quickly without waiting for culture to grow, which speeds diagnosis and can catch fastidious or non-culturable organisms that culture-based methods might miss. In contrast, methods that require culture or rely on protein fingerprints describe different approaches, not the combination of direct-from-specimen DNA amplification with mass-based identification.

Direct analysis from patient specimens is the main advantage. PCR amplifies small amounts of pathogen DNA in a sample, increasing sensitivity so low-level or hard-to-culture infections can be detected. Pairing that with ESI-TOF mass spectrometry reads the masses of the amplified products, giving a unique signature that matches known pathogens. This lets you identify the organism quickly without waiting for culture to grow, which speeds diagnosis and can catch fastidious or non-culturable organisms that culture-based methods might miss. In contrast, methods that require culture or rely on protein fingerprints describe different approaches, not the combination of direct-from-specimen DNA amplification with mass-based identification.